UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantification and molecular characterization of circulating epithelial tumor cells (CETC) for determination of their metastatic potential

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e13585-e13585

2011

Volltextzugriff (PDF)

Integration of EDP into the crossmatching laboratory and into recipient files

Beitrage zu Infusionstherapie und klinische Ernahrung, 1987, Vol.18, p.409

1987

Volltextzugriff (PDF)

163P Tumorspheres cultured from circulating cancer stem cells overexpress the innate checkpoint CD47 in breast cancer patients

Annals of oncology, 2024-09, Vol.35, p.S281-S281

2024

Volltextzugriff (PDF)

2247P Expression of PD-L1 on circulating epithelial tumor cells (CETCs) in men with primary non-metastatic prostate cancer

Annals of oncology, 2023-10, Vol.34, p.S1157-S1157

2023

Volltextzugriff (PDF)

Adjuvant radiation therapy leads to an up-regulation of programmed death ligand 1 (PD-L1) on circulating epithelial tumor cells (CETCs) which might contribute to radioresistance in primary breast cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii47-viii47

2018

Volltextzugriff (PDF)

Spheroid formation assay for in vitro assessment and expansion of circulating cancer stem cells (cCSC) in patients with breast cancer

European journal of cancer (1990), 2016-12, Vol.69, p.S54-S54

2016

Volltextzugriff (PDF)

118 Characterisation of tumorspheres cultured from circulating epithelial tumor cells (CETCs) in pancreatic cancer patients

European journal of cancer (1990), 2015-09, Vol.51, p.S6-S6

2015

Volltextzugriff (PDF)

Abstract P3-01-17: PD-L1 expression on circulating epithelial tumor cells (CETCs) correlates with aggressiveness of tumor in breast cancer patients

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-01-17

2019

Volltextzugriff (PDF)

Abstract P2-01-12: Detection of circulating cancer stem cells: A novel approach as a predictive marker for breast cancer metastases. This may be especially useful in patients with undetectable circulating epithelial tumor cells

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-01-12

2019

Volltextzugriff (PDF)

150PAdjuvant radiation therapy leads to an up-regulation of programmed death ligand 1 (PD-L1) on circulating epithelial tumor cells (CETCs) which might contribute to radioresistance in primary breast cancer patients

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

165 PDL-1 is highly expressed on circulating epithelial tumor cells (CETCs) and could be a crucial factor in the inhibition of immune response to CETCs during metastasis formation

European journal of cancer (1990), 2015-09, Vol.51, p.S18-S19

2015

Volltextzugriff (PDF)

318: Chemosensitivity differs between CETCs and spheroids grown from the CETCs in cancer patients with solid tumors

European journal of cancer (1990), 2014-07, Vol.50, p.S76-S76

2014

Volltextzugriff (PDF)

317: Analysis of HER2 amplification and IGF-IR expression in CETCs and its possible association with resistance to trastuzumab in HER2 positive breast cancers

European journal of cancer (1990), 2014-07, Vol.50, p.S76-S76

2014

Volltextzugriff (PDF)

B7-H3 (CD276) on circulating epithelial tumor cells (CETCs) correlates with proliferation marker Ki-67 and may be associated with aggressiveness of tumor in breast cancer patients

Annals of oncology, 2017-09, Vol.28, p.v580-v580

2017

Volltextzugriff (PDF)

190 Differential chemosensitivity between CETCs and tumour spheroids in cancer patients with solid tumors

European journal of cancer (1990), 2014-11, Vol.50, p.62-62

2014

Volltextzugriff (PDF)

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer

Annals of oncology, 2007-09, Vol.18 (9), p.1484-1492

2007

Volltextzugriff (PDF)

149 - Spheroid formation assay for in vitro assessment and expansion of circulating cancer stem cells (cCSC) in patients with breast cancer

European journal of cancer (1990), 2016-12, Vol.69, p.S54-S54

2016

Volltextzugriff (PDF)

The number of tumorspheres cultured from CETCs in breast cancer patients is directly related to stage of disease and administration of chemotherapy

Annals of oncology, 2016-10, Vol.27, p.vi534-vi534

2016

Volltextzugriff (PDF)

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer

Clinical chemistry and laboratory medicine, 2005-01, Vol.43 (6), p.617-627

2005

Volltextzugriff (PDF)

Abstract PD6-1: Tumor spheres growing from peripherally circulating tumor cells exhibit stem cell features

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.PD6-1-PD6-1

2013

Volltextzugriff (PDF)

Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions - results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study)

Ultraschall in der Medizin, 2015-04, Vol.36 (2), p.122-131

2015

Volltextzugriff (PDF)

Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial)

Ultraschall in der Medizin, 2008-10, Vol.29 (5), p.499-505

2008

Volltextzugriff (PDF)

Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer

Ecancermedicalscience, 2013-01, Vol.7, p.343-343

2013

Volltextzugriff (PDF)

Abstract P5-03-13: Detection of tumor initiating cells (TIC) among the peripherally circulating epithelial tumor cells from patients with breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-03-13

2012

Volltextzugriff (PDF)

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring

Breast cancer research : BCR, 2005-01, Vol.7 (6), p.R975-R979, Article R975

2005

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(64)
Deutsch
(19)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Female
(14)
Adult
(10)
Male
(10)
Amino Acyl-Trna Synthetases - Metabolism
(7)
Biological And Medical Sciences
(7)
Hematology, Oncology And Palliative Medicine
(7)
Middle Aged
(7)
Aged
(6)
Aged, 80 And Over
(6)
Kinetics
(6)
Serine-Trna Ligase - Metabolism
(6)
Blood Transfusion
(5)
Flow Cytometry
(5)
Hematology
(5)
Medical Sciences
(5)
Rna, Transfer - Metabolism
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quantification and molecular characterization of circulating epithelial tumor cells (CETC) for determination of their metastatic potential

Integration of EDP into the crossmatching laboratory and into recipient files

163P Tumorspheres cultured from circulating cancer stem cells overexpress the innate checkpoint CD47 in breast cancer patients

2247P Expression of PD-L1 on circulating epithelial tumor cells (CETCs) in men with primary non-metastatic prostate cancer

Adjuvant radiation therapy leads to an up-regulation of programmed death ligand 1 (PD-L1) on circulating epithelial tumor cells (CETCs) which might contribute to radioresistance in primary breast cancer patients

Spheroid formation assay for in vitro assessment and expansion of circulating cancer stem cells (cCSC) in patients with breast cancer

118 Characterisation of tumorspheres cultured from circulating epithelial tumor cells (CETCs) in pancreatic cancer patients

Abstract P3-01-17: PD-L1 expression on circulating epithelial tumor cells (CETCs) correlates with aggressiveness of tumor in breast cancer patients

Abstract P2-01-12: Detection of circulating cancer stem cells: A novel approach as a predictive marker for breast cancer metastases. This may be especially useful in patients with undetectable circulating epithelial tumor cells

150PAdjuvant radiation therapy leads to an up-regulation of programmed death ligand 1 (PD-L1) on circulating epithelial tumor cells (CETCs) which might contribute to radioresistance in primary breast cancer patients

165 PDL-1 is highly expressed on circulating epithelial tumor cells (CETCs) and could be a crucial factor in the inhibition of immune response to CETCs during metastasis formation

318: Chemosensitivity differs between CETCs and spheroids grown from the CETCs in cancer patients with solid tumors

317: Analysis of HER2 amplification and IGF-IR expression in CETCs and its possible association with resistance to trastuzumab in HER2 positive breast cancers

B7-H3 (CD276) on circulating epithelial tumor cells (CETCs) correlates with proliferation marker Ki-67 and may be associated with aggressiveness of tumor in breast cancer patients

190 Differential chemosensitivity between CETCs and tumour spheroids in cancer patients with solid tumors

The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer

149 - Spheroid formation assay for in vitro assessment and expansion of circulating cancer stem cells (cCSC) in patients with breast cancer

The number of tumorspheres cultured from CETCs in breast cancer patients is directly related to stage of disease and administration of chemotherapy

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer

Abstract PD6-1: Tumor spheres growing from peripherally circulating tumor cells exhibit stem cell features

Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions - results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study)

Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial)

Heterogeneity of circulating epithelial tumour cells from individual patients with respect to expression profiles and clonal growth (sphere formation) in breast cancer

Abstract P5-03-13: Detection of tumor initiating cells (TIC) among the peripherally circulating epithelial tumor cells from patients with breast cancer

Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring

Suchergebnisse filtern